NEW YORK – Foundation Medicine announced Monday its FoundationOne Liquid CDx test was approved by the US Food and Drug Administration for use as a companion diagnostic with olaparib (AstraZeneca and Merck's Lynparza).
NEW YORK – Foundation Medicine announced Monday its FoundationOne Liquid CDx test was approved by the US Food and Drug Administration for use as a companion diagnostic with olaparib (AstraZeneca and Merck's Lynparza).
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.